Xiaoli Min
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 8
- Mitochondrial Function and Pathology 3
-
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 7
- Co-authors
- Yongheng Chen (5 shared papers)Yi Cao (3 shared papers)Ming Zhao (5 shared papers)Chang Yao (1 shared paper)Zhuchu Chen (4 shared papers)Limin Liu (3 shared papers)Longyuan Hu (3 shared papers)Jia Liu (1 shared paper)
- Journals
- Journal of Cancer (3 papers)Neurochemical Research (2 papers)Frontiers in Neurology (2 papers)Clinical Epigenetics (1 paper)Journal of Integrative Neuroscience (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Xiaoli Min
37 papers receiving 425 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 109
- Neurology 39
- Immunology 91
- Molecular Biology 238
- Rheumatology 43
Countries citing papers authored by Xiaoli Min
This map shows the geographic impact of Xiaoli Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Min more than expected).
Fields of papers citing papers by Xiaoli Min
This network shows the impact of papers produced by Xiaoli Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Min. The network helps show where Xiaoli Min may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 52 | |
| 2 | 2020 | 40 | |
| 3 | 2015 | 30 | |
| 4 | 2021 | 28 | |
| 5 | 2019 | 25 | |
| 6 | 2020 | 23 | |
| 7 | 2019 | 22 | |
| 8 | 2024 | 19 | |
| 9 | 2017 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2022 | 15 | |
| 12 | 2017 | 14 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 11 | |
| 15 | 2023 | 11 | |
| 16 | 2019 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 2019 | 9 | |
| 19 | [Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy]. | 2007 | 8 |
| 20 | 2022 | 7 |
About Xiaoli Min
Xiaoli Min is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Neurology and Immunology, having authored 41 papers that have together received 430 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (8 papers), Cancer-related molecular mechanisms research (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Cerebrovascular and Carotid Artery Diseases (5 papers), Acute Ischemic Stroke Management (4 papers), T-cell and B-cell Immunology (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Cancer Research (109 citations), Neurology (39 citations), Immunology (91 citations), Molecular Biology (238 citations) and Rheumatology (43 citations). Xiaoli Min has collaborated with scholars based in China, United States and India. Frequent co-authors include Yongheng Chen, Yi Cao, Ming Zhao, Chang Yao, Zhuchu Chen, Limin Liu, Longyuan Hu, Jia Liu, Ting‐Hua Wang and Jintao Li. Their work appears in journals such as Journal of Cancer, Neurochemical Research, Frontiers in Neurology, Clinical Epigenetics and Journal of Integrative Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.